(Sharecast News) - A US court has granted a motion to dismiss filed by biotech AnaptysBio in a dispute with GSK's oncology unit, it was confirmed on Monday.
Tesaro launched litigation against AnaptysBio in November, claiming it was in breach of its agreement regarding cancer treatment Jemperli. AnaptysBio countersued, and filed...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE